Last Posted: Jul 10, 2020
- Germline and Somatic Testing in Ovarian Cancer: Shifting Sands of Recommendations.
Moore Kathleen N et al. Gynecologic oncology 2020 156(3) 515-516
- Germline mutation landscape of Chinese patients with familial breast/ovarian cancer in a panel of 22 susceptibility genes.
Wang Jiayu et al. Cancer medicine 2019 8(5) 2074-2084
- Clinical outcomes of a genomic screening program for actionable genetic conditions.
Buchanan Adam H et al. Genetics in medicine : official journal of the American College of Medical Genetics 2020 Jun
- Evaluating the Utility of Polygenic Risk Scores in Identifying High-Risk Individuals for Eight Common Cancers.
Jia Guochong et al. JNCI cancer spectrum 2020 Jun 4(3) pkaa021
- Genetic Counseling, Testing, and Management of HBOC in India: An Expert Consensus Document from Indian Society of Medical and Pediatric Oncology.
Malhotra Hemant et al. JCO global oncology 2020 Jul 6991-1008
- Cost-Effectiveness and Net Monetary Benefit of olaparib Maintenance Therapy Versus No Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-Mutated Ovarian Cancer in the Italian National Health Service.
Patrizio Armeni et al. Clinical therapeutics 2020 Jun
- Genetic counselors' perspectives on population-based screening for BRCA-related hereditary breast and ovarian cancer and Lynch syndrome.
De Simone Lenika M et al. Journal of genetic counseling 2020 Jun
- Economic Modelling of Screen-and-Treat Strategies for Brazilian Women at Risk of Hereditary Breast and Ovarian Cancer.
Simoes Correa-Galendi Julia et al. Applied health economics and health policy 2020 Jun
- Retrospective reinterpretation and reclassification of BRCA1/2 variants from Chinese population.
Li Dan et al. Breast cancer (Tokyo, Japan) 2020 Jun
- BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients.
Manchana Tarinee et al. Gynecologic oncology reports 2020 Aug 33100582
Search Result Summary
- CDC Information (13)
- NIH Information (8)
- CDC Publications (10)
- Hot Topics (295)
- Human Genome Epidemiologic Studies (1982)
- GWAS Studies (16)
- Human Genomics Translation/Implementation Studies (781)
- Genomic Tests Evidence Synthesis (70)
- Genomic Tests Guidelines (46)
- Tier-Classified Guidelines (31)
- Non-Genomics Precision Health (7)
- Pathogen Advanced Molecular Detection (5)
- Reviews/Commentaries (359)
- Tools/Methods (13)
- Ethical/Legal and Social Issues (ELSI) (15)
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.